TECENTRIQ

Google image searchProduct monograph

Active ingredient

atezolizumab, 840 MG/14 ML

DIN: 02492393

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: CONCENTRATE. SINGLE USE VIALS.

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 16-OCT-2019

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
• L01FF05 — ATEZOLIZUMAB (ATC/DDD)

Reference brand drug: Tecentriq

External Links for Tecentriq

Search on Google

• Tecentriq side effects
• Tecentriq dosage
• atezolizumab side effects
• atezolizumab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find tecentriq photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.